The Mesothelioma Guide Blog

A popular oral chemotherapy for treating genetic mutations is the focus of a new clinical trial for mesothelioma. The drug, olaparib, is a maintenance therapy for advanced ovarian...

Since the start of the COVID‑19 coronavirus pandemic, use of the term “immunocompromised” has surged — and for good reason. Immunocompromised people are at the highest...

The first preference for treating mesothelioma is surgery. If you can remove the cancerous tumors in bulk, quickly, then the chances of a long and healthy life increase...

Johnson & Johnson, the manufacturer at the center of asbestos lawsuits due to contaminated talc products, is being sued by a black women’s group, according to the New York...

The U.S. Food and Drug Administration (FDA) granted ONCOFID‑P “orphan drug status” for treating malignant mesothelioma. ONCOFID‑P is a combination of paclitaxel and...

Treatment for peritoneal mesothelioma is today where treatment was three years ago for pleural mesothelioma. Tumor treating fields are not yet acceptable for non-surgical cases....

One of the toughest parts of fighting mesothelioma is detecting the rare cancer. Most people don’t know they have it until the tumors have progressed into organ cavities. Early...

Researchers at Memorial Sloan Kettering Cancer Center hope they can discover the safest dose for mesothelin‑targeted CAR T‑cell therapy. This is the next step in ongoing...

There are various types of immunotherapy. Could pairing two of them work for malignant mesothelioma? A new study out of the National Cancer Institute is combining an immune...

The next chapter in the Johnson & Johnson asbestos saga is almost written. It might be defined by one word: bankruptcy. According to reports from the Wall Street Journal and...